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Global expression proﬁling of neurologic or psychiatric disorders has been confounded by variability among
laboratories, animal models, tissues sampled, and experimental platforms, with the result being that few genes
demonstrate consistent expression changes. We attempted to minimize these confounds by pooling dentate
granule cell transcriptional proﬁles from 164 rats in seven laboratories, using three status epilepticus (SE) epilepsy
models (pilocarpine, kainate, self-sustained SE), plus amygdala kindling. In each epilepsy model, RNA was
harvested from laser-captured dentate granule cells from six rats at four time points early in the process of
developing epilepsy, and data were collected from two independent laboratories in each rodent model except
SSSE. Hierarchical clustering of differentially-expressed transcripts in the three SE models revealed complete
separation between controls and SE rats isolated 1 day after SE. However, concordance of gene expression
changes in the SE models was only 26–38% between laboratories, and 4.5% among models, validating the
consortium approach. Transcripts with unusually highly variable control expression across laboratories provide a
‘red herring’ list for low-powered studies.
Design Type(s)
transcription proﬁling by array design • intervention design • disease state
design • parallel group design
Measurement Type(s) transcription proﬁling assay
Technology Type(s) microarray platform
Factor Type(s) treatment portion of study execution • sampling time measurement datum
Sample Characteristic(s) Rattus norvegicus • dentate granule cell
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Background and Summary
Epileptogenesis is the process that causes networks in a normal brain to become a source of epileptic
seizures. Among the numerous triggers of this process is a de novo bout of convulsive status epilepticus
(SE)1, which is deﬁned operationally as seizures lasting more than 5min (typically >30min), or a cluster
of seizures that occur so closely together that full consciousness is not regained between seizures2. Both
epidemiological and preclinical observations support the idea that status epilepticus (SE) at any age can
result in epilepsy later in life. Between 13–82% of children who experience a febrile convulsive SE
eventually develop epilepsy, with a long latent period of up to 10 years3, whereas about 30% of teens or
adults who experience SE develop epilepsy within two years1. Uncertainty surrounding the mechanisms
underlying epileptogenesis has limited progress towards interventions, although the extended time
required in both rodents and man for clinically obvious seizures to develop suggests that gene expression
changes might contribute to epileptogenesis. Numerous attempts have been made to employ
transcriptional expression proﬁles in animal models to identify early events in epileptogenesis
(e.g., refs 4–10) but, aside from transcripts pointing to an expected inﬂammatory state, no consensus
has developed regarding common transcriptional drivers of epileptogenesis.
Discrepancies among studies likely reﬂect a combination of low statistical power and technical factors
such as differences in the selection of species, variability in model methods, different brain regions
selected for study, and the predominant cell type that was investigated. To address these issues, we
assembled a group of laboratories into an ‘epilepsy microarray consortium’ to create epileptic rats using a
variety of models, with the broad objective of creating a reliable dataset of transcriptional proﬁles in a
single neuron type during the early phase of epileptogenesis. We reasoned that common transcriptional
changes among the diverse models would identify changes fundamental to epileptogenesis, irrespective of
the model used. We selected Sprague-Dawley rats because they are outbred and they avoid the substrain
differences often found with inbred mouse strains. We laser-captured dentate granule cells to avoid the
interpretive complications of pooling information from multiple cell types, to avoid changes in cellular
makeup due to injury, to minimize the contribution of cell death pathways compared to analysis of dying
CA1 or CA3 pyramidal neurons11, and because these neurons control generalization of seizures through
hippocampal circuits12–15. Additionally, the number of differentially expressed transcripts in dentate
granule cells 1 day after brief kainate-induced seizures was 4–10 times higher than in the CA1 or CA3 cell
layers16, so the transcriptional response of these neurons to seizures is high. To minimize model-speciﬁc
conclusions, four different epilepsy models were studied: SE caused by systemic pilocarpine or kainate, or
electrical stimulation (SSSE); a fourth model, amygdala kindling, is not based on SE but instead relies on
twice-daily 1 s duration electrical stimulation of the amygdala.
Each model was studied in two independent laboratories to mitigate laboratory-to-laboratory
variability. Dentate granule cells were harvested from tissue generated by each laboratory. Rats were
produced at each of three time points plus controls, and hemibrains from all rats were examined
histologically in a single laboratory to identify outliers that had much more (or less) neurodegeneration
than expected. Figure 1 shows the study design. The initial goals of this study were to: a) identify
model-independent transcriptional changes in dentate granule cells that might point to novel
intervention targets for epileptogenesis, b) characterize the basal transcriptional proﬁle of dentate
granule cells, and c) identify genes that have highly variable expression. The data, deposited in NCBI
GEO, are the source of several ongoing analyses (e.g., Roopra and Dingledine, in preparation; Srivastava
et al., in preparation), and should be a valuable resource for future efforts to understand the process of
epileptogenesis based on analyses of transcriptional proﬁles across animal models and laboratories.
Moreover, the data from untreated rats were obtained from 41 animals across seven laboratories, and
thus provide a comprehensive picture of the basal transcriptional proﬁle of dentate granule cells.
Methods
Overview of experimental design
We attempted to harmonize methods and, where possible, have procedures performed by a single
laboratory or individual to reduce technical variability. Thus, a) each of the two paired laboratories for
each animal model agreed upon the procedure to be followed; b) all tissue was sent to a single laboratory
(RD), who distributed it for histology and laser capture microdissection (LCM); c) all histology was done
in a blinded fashion at a single laboratory (RSS), and LCM at two laboratories (PS and RD); d) the
microarray procedures were carried out at a single site (TGEN, Phoenix, AZ).
Animal models and tissue preparation
All animal procedures were performed in accordance with NIH guidelines or EU Directive for the
protection of laboratory animals, and were approved by the IACUC of each consortium members’
institution. The animals used in this study were male Sprague-Dawley rats obtained from Charles River.
Individually housed animals were handled and allowed to acclimatize for at least 1 week prior to
experiments, with food and water available ad libitum. Each laboratory provided tissue from 24 animals,
six per group (controls and three groups post-SE or at deﬁned kindling stages). Control animals were
collected at each of the three time points.
www.nature.com/sdata/
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Pilocarpine model (RD, DC). Sprague-Dawley rats (180–200 g) were purchased from Charles-River
(Raleigh, NC). Rats were given an injection of methylscopolamine (1 mg kg1, i.p., Sigma) to minimize
peripheral cholinergic effects of pilocarpine. After 30 min, animals received pilocarpine hydrochloride
(300–350 mg kg1 sc, Sigma) or saline. Seizures were classiﬁed according to Racine17 and Schauwecker
and Steward18 with slight modiﬁcations11. SE was deﬁned by continuous seizure activity consisting of
stage 4 to 6 seizures. SE was terminated with pentobarbital (25 mg kg1, i.p., McKesson) after 90 min of
SE activity. Animals were monitored daily and given dextrose in lactate Ringer solution (~1 ml, i.p.) as
needed. Control rats were given methylscopolamine and pentobarbital, but saline instead of pilocarpine.
Kainate model (WW/JG and VN). Sprague Dawley rats (175–250 g) were purchased from Charles-
River, Raleigh (VN) or Harlan, Netherlands (WW/JG). The Netherlands group used an initial
intraperitoneal injection of 7.5 mg kg1 kainic acid, followed by 5 mg kg1 kainate hourly until SE
induction; seizure activity was stopped with pentobarbital 90 min after SE onset. The Duke group injected
rats with kainic acid (5 mg kg1, i.p.) hourly until status epilepticus was achieved and then allowed SE to
self-terminate after 6–8 h. All animals received 5–6 injections before SE onset. SE onset was deﬁned by
continuous stage 4 and stage 5 seizure activity. Control rats were given saline at the same schedule.
Self-sustained status epilepticus (SSSE) model (AP, CW). Male Sprague-Dawley rats were purchased
from Charles River at 280–300 g. The animals were implanted with a stimulating electrode in the left
angular bundle (in reference to lambda AP +0.5 mm, ML +4.5 mm, depth −4.0 mm from surface of
brain). Electrodes were positioned under isoﬂurane anesthesia (4% in O2), and animals were treated for
post-operative pain with buprenorphine for three days following surgery. Rats were allowed to recover for
14 days before initiating SE. EEG was recorded from skull screws located over the dorsal hippocampi. The
stimulation wave form consisted of 10 s trains of 20 Hz biphasic square waves delivered at 1 train per
minute superimposed on continuous 2 Hz monophasic square waves. All square waves were 1 msec in
duration. Animals received no treatment following stimulation of the perforant path and were included in
the study if they remained in SE 10 min after the end of perforant path stimulation19. Intermittent stage
1–5 kindling-like seizures, and electrographic seizures that were initially nearly continuous and later
became separated by periods of low-voltage activity, continued for many hours. The mean duration of SE
was 8.2± 2.1 h20. Control animals were implanted but not stimulated.
Kindling (JM, MR). Male Sprague-Dawley rats, 180–200 g at time of receipt, were obtained from
Charles River. One week later a bipolar electrode was stereotaxically implanted in the right amygdala
under pentobarbital anesthesia (60 mg kg1, i.p.), and animals allowed to recover for 5–14 days. The
electrographic seizure threshold was determined by administering a 1 s train of 1 msec biphasic
rectangular pulses at 60 Hz beginning at 60 μA. Additional stimulus trains increasing by 20 μA were
administered at one minute intervals until an electrographic seizure lasting at least 5 s was detected on the
electroencephalogram (EEG) recorded from the amygdala. Stimulation was subsequently administered at
Figure 1. Workﬂow scheme. The number of rats from which high quality RNA was obtained is shown for
each condition tested. Control in the case of kindling is sham stimulation. Abbreviations: RD, DC etc on the
‘Lab’, ‘Process’ or ‘Analysis’ rows are initials of the responsible authors; CON—control rats that had been
injected with vehicle (pilocarpine and kainate models), or implanted but not stimulated (SSSE and kindling
models); SE 1 day—rats sacriﬁced 1 day after experiencing status epilepticus (SE); K stage 2—rats undergoing
kindling that were sacriﬁced 24 h after the ﬁrst Stage 2 seizure. SSSE—self-sustained status epilepticus,
produced by continuous electrical stimulation of the angular bundle.
www.nature.com/sdata/
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this intensity twice daily. Unstimulated control animals underwent surgical implantation of an electrode
in amygdala but were not stimulated. Behavioral seizure class was scored according to Racine’s
classiﬁcation17: Stage 0, no behavioral change; Stage 1, facial clonus; Stage 2, head nodding; Stage 3,
unilateral forelimb clonus; Stage 4, rearing with bilateral forelimb clonus; Stage 5, rearing and falling
(loss of postural control). Datasets were generated from animals early in the kindling process (24 h after
the ﬁrst Stage 2 seizure), at the completion of kindling (24 h after the ﬁrst Stage 4 or 5 seizure), and after
kindling had been established and was stable over time (24 h after the 10th Stage 4 or 5 seizure).
Tissue handling. Animals that entered status epilepticus (SE) were killed for tissue harvest at 1 day
(23–25 h), 3 days (70–74 h), or 10 days after SE onset. Brains were removed from kindled rats 24 h after
the ﬁrst stage 2 seizure, 24 h after the ﬁrst stage 5 seizure or 24 h after the tenth stage 5 seizure. At each
time point, the animal was decapitated following deep ether or isoﬂurane anesthesia. Brains were
removed and longitudinally bisected. The left half of each brain was immersed in 4% (w/v)
paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.4 and stored at 4 °C, while the right half
was frozen on dry ice and stored at −80 °C in foil. Each consortium laboratory followed the same
procedure for brain tissue preparation. All tissue was sent to one laboratory (RD) and subsequently the
ﬁxed brains were sent to RSS for Nissl stain histology and to assess the extent of damage incurred. The
frozen half of the brains from the pilocarpine and kainate epilepsy models were sent to PS for laser
capture microscopy of dentate granule cells. Laser capture for the brains produced by SSSE was done at
Emory University. Our goal was to process tissue from 6 rats at each time point from each laboratory,
although as Fig. 1 indicates, some brains had thawed in shipment and were thus unusable.
Laser capture microdissection and RNA isolation
Ten micron coronal sections were taken through the hippocampus and collected onto uncoated
microscope slides, refrozen on dry ice, and stored at −80 ° C until staining for LCM. For staining, sections
were ﬁxed in ice-cold 70–75% ethanol for 30 s, rinsed in water 10–15 s, dipped in cresyl violet stain
10–15 s, rinsed in H2O for 10 s, then dehydrated through alcohols over 2 min to xylene. Sections were
dried in a fume hood and LCM was performed within 1 hour. LCM was performed using a Veritas or
Pixcell IIe system with transmission illumination (Arcturus, CA) and the following parameters: spot
size= 25–30 μm; power= 50–65 mW; duration= 1,700–3,000 μs per hit. The middle of the dentate
gyrus was harvested (Fig. 2) from 10–16 sections per subject in order to avoid the neurogenic zone of
the hilar-granule cell border. LCM HS Caps (Arcturus) were used to collect dentate granule cells with
2–5 sections per cap, resulting in 2–8 LCM Caps used per subject and at least 10 ng total RNA for
ampliﬁcation.
Total RNA was extracted from each LCM cap using the PicoPure Isolation Kit (Arcturus) with DNase
digestion (Qiagen Rnase-free DNase Set), and stored at −80 °C until RNA quality veriﬁcation and
quantiﬁcation using Agilent RNA 6,000 PicoChips run on the Agilent 2,100 Bioanalyzer. The results of
the PicoChip determined whether the RNA was of high enough quality to keep for ampliﬁcation and later
hybridization. Total RNA with 28S:18S rRNA ratio >0.8 and RNA Integrity Number (RIN)>6.9 was
accepted from each LCM cap in order to obtain one pooled sample from each rat with a minimum of 10
ng total RNA. Once a total RNA pool was complete for each subject, the sample was assessed by the
BioAnalyzer, quantity and quality recorded, and samples were frozen at −80 °C until shipment to TGEN
for RNA ampliﬁcation and microarray hybridization.
Figure 2. Laser capture harvesting of cells in the middle of the dentate granule cell layer in the outer leaf.
Left: diagram of hippocampus with CA1 and CA3 pyramidal cell layers and the dentate gyrus (DG). Laser
capture was done from the boxed region and shown in the right panel. Cresyl violet stain of a section from a rat
treated with pilocarpine 10 days before. The region of captured dentate granule cells is indicated by the absence
of blue stain.
www.nature.com/sdata/
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Microarray hybridization
The NINDS NIMH Microarray Consortium at the Translational Genomics Institute in Phoenix,
AZ (TGEN) performed RNA ampliﬁcation, sample labeling, microarray hybridization, and submission of
the data to NCBI GEO. Brieﬂy, TGEN ampliﬁed the RNA once, reverse-transcribed the RNA to cDNA
and used this to produce biotinylated cRNA with the EnzoBioArray High Yield RNA Transcript Labeling
Kit (Affymetrix, CA). Samples (10 μg) were hybridized for 16 h at 45 °C on the GeneChip Rat Genome
230 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400. Probe creation
and hybridization was done by two technicians at TGEN; JM, MR, VN and CW samples were processed
by one technician, whereas RD, DC and WW samples were processed by a second technician. The
RAE230A is a high-density microarray that surveys over 10,000 unique transcripts. GeneChips were
scanned using the GeneArray Scanner G2500A. The data were analyzed with Microarray Suite version 5.0
(MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The
mean target intensity of each array was set to 150. All image ﬁles and data from hybridizations are
available at the NCBI GEO website, with access number GSE47752 (Data Citation 1).
Neuropathology
Fixed half-brains from each laboratory were sent to RSS for histological assessment of cell damage and
neuronal death in the hippocampus. For each brain, 40-μm-thick coronal sections were cut in 0.1 M Tris
(hydroxymethylaminomethane) buffer pH 7.6, with a Vibratome. Regularly spaced sections were
mounted on subbed slides for subsequent Nissl (1% cresyl violet) staining. After staining, all slides were
dehydrated in graded ethanols and xylene and then coverslipped with Permount21. All tissue from
SE-induced animals was assessed against that of controls for cell damage in various areas of the
hippocampus, including the CA1, CA3, hilus, dentate gyrus, and piriform cortex. An outlier of SE-brains
was deﬁned as either a) one with no discernable neuron death in CA3 or CA1, or b) a brain with an
extremely injured hippocampus that includes substantial granule cell death. No outliers were found, so
data from all rats were included in the analysis.
Microarray data processing
Affymetrix CEL and Rat230_2.cdf ﬁles were used for RMA normalization with background adjust,
quantile normalization and median polish. Annotation was performed using netaffx build 35. RMA
normalization was performed using all probes regardless of Affymetrix ‘Present’ (P) or ‘Absent’ (A) calls.
Subsequently, only probes with the ‘_at’ sufﬁx were retained to ensure that only probes speciﬁc to a single
gene were carried forward for further analysis. Probe level data were then collapsed to gene symbols with
the symbol being designated ‘Present’ in a RNA sample if at least 50% of probes for that symbol were
designated as ‘Present’. To designate genes as expressed or not over the entire experiment the following
rules were applied: A symbol was designated ‘above background’ in a laboratory for a given status
epilepticus time point and epilepsy model (e.g., Day 1 after pilocarpine SE, see Fig. 1) if it was labelled
‘Present’ in at least 3 of the animals at that time point. A gene symbol was designated as ‘above
background’ for a speciﬁc time point if it was labelled ‘Present’ in at least 4 of the 5 SE laboratories
(i.e., no more than 1 lab could call the symbol ‘Absent’). For the control condition, the symbol was
considered above background if it was called Present in at least 6 of the 7 laboratories (i.e., no more than
1 laboratory could call the symbol ‘Absent’). Finally, a symbol was designated ‘above background’ over
the entire analysis if it was called as Present in any time point. For each gene symbol accepted for the
entire analysis, expression values for every animal were included regardless of its Absent or Present call in
any individual animal. In summary: A symbol is expressed above background in a laboratory at a given
time point if it is labeled as Present in at least 3 animals. A symbol is above background in SE if it is
Present in at least 4 laboratories. For controls, the symbol is above background if it is labeled Present in at
least 6 laboratories.
To cluster expression values pooled across SE models and laboratories, the expression level of each
gene symbol in a laboratory was collapsed to its median log2 value across animals in that laboratory.
A total of 9,614 symbols were Present in at least 1 of the 4 conditions (control, 1- day, 3-days, 10-days
after SE). Paired t-tests compared expression levels after SE with control values and n= 5 labs, then a
correction22 was made for multiple comparisons to adjust the false discovery rate (FDR) to 0.05.
Altogether there were 2,646 differentially expressed genes after SE at any of the three time points
examined in this analysis. Unsupervised hierarchical clustering was performed using median values of the
368 genes that were differentially expressed at least 2-fold between controls and SE rats, with uncentered
Pearson correlations and complete clustering. To determine the degree of overlap between differentially
expressed genes 1 day after SE among the three models, unpaired t-tests were run separately on data from
each of the 5 laboratories (FDRo0.05)22 and a Venn diagram approach used.
Data Records
CEL and CHIP ﬁles associated with this analysis are deposited in the Gene Expression Omnibus
(https://www.ncbi.nlm.nih.gov/gds/) with the accession number GSE47752 (Data Citation 1). Detailed
information about each sample is in Table 1 (available online only).
www.nature.com/sdata/
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Technical Validation
Several aspects of the experiment were designed to improve the quality of the data. First, RNA was
harvested from the middle of the dentate granule cell layer (Fig. 2) both to minimize contributions from
multiple cell types that would have occurred had we used whole tissue (e.g., hippocampus) instead, and to
avoid contamination by cells undergoing neurogenesis at the hilar-granule cell border. However, low to
moderate levels of RNA from glial processes found in the cell layer are included; e.g., the microglial
transcript that encodes Iba1 is expressed at a level of 104, the oligodendrocyte marker MBP is 612 and the
astrocytic marker GFAP is 2,219. Second, we gathered data in parallel from 4 epilepsy models to provide
a database from which model-independent conclusions can be drawn. Third, we intended that two
independent laboratories study each animal model to reduce lab-to-lab inﬂuences; this was successful
except for the SSSE model as described above. Fourth, 6 rats (occasionally 4–5) were provided for each
treatment group from each laboratory; e.g., the control group was derived from 41 rats in 7 laboratories.
Fifth, to minimize technical variation the LCM harvest of RNA from 144 of the 164 samples was done in
one laboratory by the same technician, and the remainder (the SSSE samples) in a second laboratory;
likewise RNA ampliﬁcation, hybridization probe generation, microarray hybridization and initial data
Figure 3. Quality control assessment for microarrays of the RNA samples from 164 rats. (a) Signal values
from 4 bacterial or viral RNAs that had been spiked into each sample RNA before probe labeling are plotted for
each of the 164 RNA samples. Boxplots of median expression across all arrays are shown to the right. Labels a-g
denote data from the seven laboratories. Labels 1–4 are different prokaryotic or phage RNAs spiked at
increasing levels. (b) Median 30/50 intensity ratios from 10 transcripts in each sample are plotted. (c) Excellent
correlation between expression in the control condition of the 9,327 transcripts in the ﬁrst kainate laboratory
(KA-1) and the ﬁrst pilocarpine laboratory (pilo-1). The heatmap below shows Pearson’s correlations between
median control expression in all combinations of the 7 laboratories; correlations range from 0.973 to 0.998.
(d) Histogram of the median expression level of each expressed gene in the control condition across all 7
laboratories is normal (Kolmogorov-Smirnov test). (e) The coefﬁcient of variation is plotted versus the median
expression for each of 9,327 transcripts in the control condition across 7 laboratories, revealing a subset of 59
genes with very tight expression across laboratories (o3% cv) and a subset of 87 genes with very variable
expression. (c–e): A transcript was selected for inclusion if at least 6 of the 7 laboratories had no more than
3 absent calls each (mean of 0.26 absent calls/gene/lab).
www.nature.com/sdata/
SCIENTIFIC DATA | 4:170061 | DOI: 10.1038/sdata.2017.61 6
reduction were done at a single site (TGEN in Phoenix, AZ) by two technicians. Finally, RNA quality was
controlled by accepting pooled samples from a rat if the RIN≥ 6.9, the ratio of 28S to 18S rRNA was
≥0.8, and at least 10 ng of total RNA had been obtained from the granule cells.
To explore the technical quality and uniformity of the raw microarray data, we carried out
two diagnostic tests. Into each RNA sample Affymetrix routinely spikes RNAs from three E. coli genes
(bioB, bioC, bioD) and the bacteriophage cre recombinase to assess the overall success of probe synthesis,
hybridization and microarray imaging. We plotted the array signals from each of these 4 spikes over the
164 rat samples in Fig. 3a. Success requires that signal intensities from these 4 spikes show increasing
values. The associated boxplots of median expression of these spikes demonstrate that the 4 RNA spikes
are present at the expected increasing levels. Importantly, the lowest level spike was called ‘present’ in
all 164 samples. Second, we plotted the median ratio of signal intensities for probes hybridizing to the
3’ and 5’ regions of 7 spiked RNAs and 3 endogenous RNAs to assess RNA degradation during the
process. Figure 3b shows that all 164 samples had a 3’/5’ ratioso3, indicative of acceptable RNA quality.
To further examine the quality of the data and the consequences of our experimental design we carried
out several additional tests on data that were ﬁltered as described above. To determine variation of
expression levels across laboratories we considered the 41 controls provided by all 7 laboratories.
The samples provided by each lab showed high correlation of signal intensities over the 9,327 transcripts
studied (Fig. 3c). Pearson correlation coefﬁcients ranged from 0.973 to 0.998 as shown in the heatmap in
Fig. 3c. The median expression intensities of each transcript were then calculated across the 7
laboratories, with each laboratory donating a single expression value for each transcript derived from the
median of all control rats. A histogram of median log2 values of expression in the control condition
across the 7 sites was normally distributed (Fig. 3d), with no ‘excess’ representation of low-expressing
noise transcripts. A plot of the coefﬁcient of variation of expression level across laboratories for each of
the 9,237 transcripts versus its median expression level (Fig. 3e) showed that the mean CV of expression
was 14%. Moreover, this plot revealed the presence of transcripts with highly stable expression across
sites (n= 59 with CVo3%, see Table 2 (available online only)), and transcripts with highly variable
expression (n= 87 with CV>3 SDs above the mean, see Table 3 (available online only)). The high
variability group of transcripts represent potential ‘red herrings’ in transcriptional proﬁling studies that
have low power.
To determine whether our strategy of comparing animal models and of having two independent
laboratories study each animal model was worthwhile, we focused on the SE models for which we have
the most data. We ﬁrst performed a hierarchical clustering of expression levels across all four time points
and three SE models (control and 1, 3 or 10 days after SE), with data from all rats in each group from
each laboratory having been condensed to their median expression level for each transcript. Figure 4
shows complete separation of the 5 control groups and the 5 SE groups 1 day after SE, whereas proﬁles
from the 3 day and 10 day groups were somewhat intermixed. This suggests that the datasets are
sufﬁciently robust at the group level to distinguish SE from control rats reliably in all laboratories, which
is a prerequisite for future studies of the whole dataset. Second, to determine whether our experimental
design incorporating multiple laboratories to study each animal model was necessary, we used a Venn
diagram approach to compare transcript levels 1 day after SE in the pilocarpine, kainate and SSSE
models. We found low congruence between paired laboratories and especially among the three models
(Fig. 5). Very few transcripts were differentially expressed in any of the kindling groups, and none of
those overlapped with the SE groups. These results validate the importance of a consortium strategy for
the goal of identifying the relatively small number of transcripts that are differentially expressed in a
laboratory- and model-independent fashion. Thus, 1 day after SE only 73 out of 1,638 transcripts
differentially expressed in any model in any laboratory (4.5%) were in common across all laboratories and
models. These transcripts (Table 4 (available online only)) represent genes whose differential expression
in response to SE was independently replicated for each model and laboratory combination. The large
group of transcripts that do not overlap in the Venn diagrams may reﬂect expression changes unique to
each treatment model or laboratory. The results suggest that all three SE models converge at the one day
time point on a rather small common set of gene expression changes associated with the early
development of epilepsy, or potentially with nearby brain injury. Our dataset of transcripts with the most
reproducible changes in expression (Table 4 (available online only)) should be useful for numerous
analyses of seizure-induced gene expression changes in the rat. None of these transcripts appears in
Tables 2 and 3 (available online only).
The deposited data on transcriptional responses of dentate granule cells to SE 1, 3 and 10 days later,
and throughout the kindling process, provide a reference dataset that can be extended in multiple ways. It
would be useful to compare dentate granule cells with other cell types thought to be involved in
epileptogenesis, for example the principal neurons in layer II of the medial entorhinal cortex23 or
astrocytes24,25. It would also be worthwhile to examine transcriptional responses earlier in the process
(e.g., 1–6 h after SE onset), during which neurogenic inﬂammation is initiated26. Finally, other epilepsy
models such as febrile SE27, post-traumatic epilepsy28 or genetic epilepsies that do not involve overt
neurodegeneration29, could be considered. The genetic epilepsies might avoid transcriptional changes due
to a bystander effect of nearby dying neurons; mice bearing epilepsy genes with late expression onset
would lend themselves to the kind of temporal analysis done here but could suffer from effects on
development unrelated to epileptogenesis. The cost of RNAseq analyses has now ebbed to the point at
www.nature.com/sdata/
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Figure 4. Hierarchical clustering of differentially expressed genes across laboratories and SE epilepsy
models. Unsupervised hierarchical clustering was performed using median log2 values of the 368 genes that
were differentially expressed (FDRo0.05) at least 2-fold between controls and SE-experienced rats, in any
model and any lab, with uncentered Pearson correlations and complete clustering.
Figure 5. Low congruence of differentially-expressed genes across laboratories and animal models of
epilepsy 1 day after SE. The circles in the top row show overlap between laboratories studying the same
epilepsy model, and the bottom compares differentially expressed genes among the three epilepsy models.
www.nature.com/sdata/
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which it could be used in future studies and would open the analysis to splicing isoforms of individual
transcripts and to non-coding RNAs e.g., miRNAs and lncRNAs. Regardless how this study is extended, it
is worth recognizing the value shown here of utilizing multiple models and multiple investigators, and
harvesting RNA from single cell types to limit noise in the transcriptome.
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